WDA license vs GDP: How They Connect in Pharma

Introduction

Pharmaceutical distribution in the UK is built on a strict regulatory structure designed to protect patient safety and product integrity. Two terms sit at the centre of this structure and are often mentioned together, the WDA license and Good Distribution Practice, commonly known as GDP. While they are closely linked, they are not the same thing. Confusion between these two concepts is common and can lead to compliance gaps, failed inspections, or rejected applications.

This article explains the relationship between the WDA license and GDP, how they interact in pharmaceutical distribution, and why understanding their connection is essential for any organisation involved in wholesale supply of medicinal products. The content is particularly relevant to pharmaceutical and healthcare businesses operating in London, where regulatory oversight is detailed and expectations are high. Readers familiar with guidance provided through specialist services such as InGlasia’s WDA licence support in London will recognise the regulatory themes discussed throughout this guide.

Understanding the WDA license

A WDA license, or Wholesale Distribution Authorisation, is a legal approval issued by the Medicines and Healthcare products Regulatory Agency. It allows a business to carry out wholesale distribution of medicinal products within the UK or between the UK and other approved markets.

Wholesale distribution includes activities such as procurement, holding, supply, and export of medicines, excluding direct supply to patients. A key fact is that the WDA license applies to responsibility and control, not just physical handling. Even organisations that never touch products may still require a licence if they control supply decisions.

Another important detail is that the WDA license is site specific. Each location involved in wholesale activities must be declared and assessed by the MHRA.

What Is GDP in Pharmaceutical Distribution?

Good Distribution Practice sets the standards that ensure medicines are consistently stored, transported, and handled under suitable conditions throughout the supply chain.

GDP is a legally binding requirement for any holder of a WDA license. It defines how systems should be designed, how people should be trained, and how activities should be documented.

GDP principles cover areas such as:

Quality management systems
Personnel responsibilities and training
Premises and equipment
Documentation and record keeping
Complaints, recalls, and deviation management

One lesser known fact is that GDP applies equally to large wholesalers and small virtual distributors. The MHRA does not scale requirements based on company size.

The Legal Relationship Between WDA license and GDP

The WDA license is the legal permission to operate. GDP is the rulebook that governs how that operation must function.

Holding a WDA license without complying with GDP is not possible in practice. During inspections, the MHRA assesses GDP compliance as the primary measure of whether a licence should be granted, maintained, or suspended.

In simple terms, the WDA license answers the question of whether you are allowed to distribute medicines. GDP answers the question of whether you are doing it correctly.

Why GDP Is Central to Every WDA license Application

When applying for a WDA license, GDP compliance is assessed before approval is granted.

GDP as the Foundation of Approval

The MHRA does not issue a WDA license based solely on business intent. Inspectors evaluate whether GDP systems are fully implemented and effective.

This includes:

Written procedures that reflect real operations
Evidence of training and staff understanding
Records that demonstrate ongoing control

A useful insight is that applications are often delayed or rejected not because GDP procedures are missing, but because they are not followed in practice.

Quality Management Systems: Where WDA license and GDP Meet

The quality management system is where the WDA license and GDP intersect most clearly.

GDP requires a structured approach to quality. The WDA license makes this structure enforceable by law.

Core Quality Elements Required

A compliant quality system under a WDA license must include:

Document control
Deviation and incident management
Complaints handling
Product recall procedures
Change control

Inspectors assess not only whether these elements exist, but whether they are used consistently.

A unique fact is that internal audits are not optional under GDP. They provide evidence that the WDA license holder actively monitors compliance rather than relying on external inspections.

Responsible Person: The Human Link Between WDA license and GDP

The Responsible Person role is mandatory for every WDA license holder and is central to GDP compliance.

Responsibilities Under GDP

The Responsible Person ensures that:

GDP standards are implemented and maintained
Deviations are investigated and resolved
Supply decisions comply with regulatory requirements

The MHRA places significant emphasis on this role. During inspections, Responsible Persons are often interviewed in detail to assess knowledge and authority.

An important detail is that the Responsible Person must have sufficient independence. If they cannot act without senior management approval, inspectors may question whether GDP oversight is effective.

Premises and Storage Controls Under GDP and the WDA license

Physical premises are assessed under both GDP and the WDA license framework.

Temperature Control and Monitoring

GDP requires medicines to be stored within defined temperature ranges. Under a WDA license, failure to demonstrate temperature control can result in enforcement action.

Inspectors expect:

Temperature mapping of storage areas
Continuous monitoring systems
Documented responses to excursions

One notable fact is that temperature mapping must reflect real operating conditions. Seasonal variation is taken into account during inspections.

Security and Stock Segregation

GDP requires secure storage and clear segregation of stock. This includes quarantined, returned, or recalled products.

Under a WDA license, poor segregation is often viewed as a serious deficiency because it increases the risk of incorrect supply.

Supplier and Customer Controls: A Shared Requirement

GDP places responsibility on the WDA license holder to ensure medicines only move through authorised supply routes.

Supplier Qualification

GDP requires verification that suppliers hold appropriate licences. This includes initial approval and ongoing monitoring.

A detail often overlooked is that supplier qualification must be documented. Informal checks do not meet GDP expectations.

Customer Approval

The same level of control applies to customers. Under a WDA license, supplying to unauthorised entities can lead to licence suspension.

Inspectors often review customer approval records to assess how well GDP controls are embedded.

Documentation and Records Under GDP and the WDA license

Documentation is a central theme in both GDP and WDA license compliance.

Why Records Matter

GDP requires records to be accurate, legible, and retrievable. The WDA license makes failure in this area a regulatory issue.

Records commonly reviewed during inspections include:

Training logs
Temperature records
Supplier and customer checks
Deviation reports

A useful insight is that inspectors often select records at random. Gaps suggest systemic issues rather than isolated errors.

Training Requirements: GDP in Daily Practice

Training is a shared obligation under GDP and the WDA license.

Role Specific Training

GDP requires training to reflect job responsibilities. Warehouse staff, quality personnel, and managers require different levels of understanding.

Generic training programmes often fail to meet inspection expectations.

Training as Evidence of Control

Under a WDA license, training records demonstrate that GDP principles are understood across the organisation. Inspectors frequently use training discussions to assess compliance culture.

Virtual Wholesalers and GDP Obligations

Virtual wholesalers are a common source of misunderstanding.

Even without physical storage, organisations that control transactions require a WDA license and must comply with GDP.

GDP still applies to:

Supplier qualification
Customer approval
Record keeping
Oversight of third party logistics providers

A notable fact is that outsourcing logistics does not transfer responsibility. The WDA license holder remains accountable for GDP compliance.

Inspections: How GDP Is Tested Under a WDA license

MHRA inspections focus on how GDP operates in practice.

Inspectors assess:

Alignment between procedures and reality
Staff understanding of responsibilities
Effectiveness of quality oversight

One inspection trend is increased focus on data integrity. Electronic systems must be secure and auditable.

A WDA license holder with weak GDP implementation may face delayed approval or enforcement action.

Common Misunderstandings About WDA license and GDP

Several misconceptions lead to compliance issues.

Believing GDP is guidance rather than a legal requirement
Assuming third party providers carry compliance responsibility
Treating GDP as a one time setup

Understanding that GDP is an ongoing obligation under the WDA license helps avoid these pitfalls.

The London Regulatory Environment and GDP Expectations

London based pharmaceutical operations often involve complex supply chains, shared facilities, and cross border activity.

MHRA inspectors are familiar with these models and expect high levels of control under both GDP and the WDA license.

Specialist providers such as those referenced on InGlasia’s WDA licence in London service pages often focus on aligning systems with these heightened expectations.

How Expert Support Helps Align GDP and the WDA license

Many organisations seek external support to align GDP systems with WDA license requirements.

Support may include:

Gap assessments
Procedure review
Inspection readiness preparation

Experienced advisors help translate regulatory requirements into workable processes without compromising compliance.

Why WDA License Expertise Matters

Understanding the connection between GDP and the WDA license requires practical experience. WDA License specialists are recognised for their knowledge of MHRA expectations and how GDP is applied across different distribution models.

Their insight helps organisations maintain compliance throughout the licence lifecycle.

Take the Next Step With WDA license and GDP Compliance

Work With Trusted WDA license Specialists

If your organisation is applying for a WDA license or reviewing GDP compliance, expert guidance can provide clarity and regulatory confidence. WDA License is recognised as an industry authority, supporting pharmaceutical and healthcare businesses across London and the wider UK.

Take action by reaching out to the WDA License team and completing their contact form to discuss your distribution model and compliance needs.